Healthcare / Medical Care FacilitiesSantiago
$2713.30
+13.30 (+0.49%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $16.6B · quality 60.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
59/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$416.3B
P/E
24.9x
↑EV/EBITDA
14.6x
↑ROE
7.6%
↑Gross Margin
26.0%
↓Debt/Equity
0.48
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+12.5%
FCF CAGR
—
FCF margin
7.9%
FCF / Net income
1.38x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $272.31B · net income $15.66B · FCF $21.64B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $272.31B | $272.31B | $239.07B | $218.93B | $191.29B |
| Net Income | $15.66B | $15.66B | $7.28B | $144.3M | $13.05B |
| EBITDA | $32.32B | $32.32B | $16.53B | $7.10B | $18.44B |
| EPS | 109.00 | 109.00 | 50.56 | 0.97 | 90.42 |
| Gross Margin | 26.0% | 26.0% | 24.3% | 20.5% | 23.8% |
| Operating Margin | 4.6% | 4.6% | 6.1% | 1.9% | 6.8% |
| Net Margin | 5.8% | 5.8% | 3.0% | 0.1% | 6.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.48 | 0.48 | 0.95 | 1.11 | 1.11 |
| Current Ratio | 1.13 | 1.13 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $21.64B | $21.64B | $16.65B | $9.30B | $-2.36B |
| Returns | |||||
| ROE | 7.6% | 7.6% | 6.7% | 0.1% | 12.8% |
| Valuation | |||||
| P/E | 24.87 | 24.87 | 31.05 | 1299.09 | 17.80 |
| EV/EBITDA | 14.61 | 14.61 | 19.41 | 40.18 | 18.00 |
| P/B | 1.88 | 1.88 | 2.08 | 1.76 | 2.29 |
| Growth & Yield | |||||
| Revenue Growth | 13.9% | 13.9% | 9.2% | 14.5% | — |
| EPS Growth | 115.6% | 115.6% | 5100.0% | -98.9% | — |
| Dividend Yield | 1.6% | 1.6% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
30.2%
EPS terminal req.
$240.76
Spread vs growth
85.4%
5Y implied EPS CAGR
21.7%
EPS terminal req.
$291.32
Spread vs growth
93.9%
10Y implied EPS CAGR
15.7%
EPS terminal req.
$469.17
Spread vs growth
99.9%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+33.9%
Start / end P/E
40.5x → 24.9x
EPS bridge
50.56 → 109.00
Residual
-44.6%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.